[go: up one dir, main page]

GB201107176D0 - Pyrrolnitrin derivatives - Google Patents

Pyrrolnitrin derivatives

Info

Publication number
GB201107176D0
GB201107176D0 GBGB1107176.8A GB201107176A GB201107176D0 GB 201107176 D0 GB201107176 D0 GB 201107176D0 GB 201107176 A GB201107176 A GB 201107176A GB 201107176 D0 GB201107176 D0 GB 201107176D0
Authority
GB
United Kingdom
Prior art keywords
pyrrolnitrin
derivatives
pyrrolnitrin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1107176.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CXR Biosciences Ltd
Original Assignee
CXR Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CXR Biosciences Ltd filed Critical CXR Biosciences Ltd
Priority to GBGB1107176.8A priority Critical patent/GB201107176D0/en
Publication of GB201107176D0 publication Critical patent/GB201107176D0/en
Priority to PCT/GB2012/050937 priority patent/WO2012146936A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1107176.8A 2011-04-28 2011-04-28 Pyrrolnitrin derivatives Ceased GB201107176D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1107176.8A GB201107176D0 (en) 2011-04-28 2011-04-28 Pyrrolnitrin derivatives
PCT/GB2012/050937 WO2012146936A1 (en) 2011-04-28 2012-04-27 Pyrrolnitrin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1107176.8A GB201107176D0 (en) 2011-04-28 2011-04-28 Pyrrolnitrin derivatives

Publications (1)

Publication Number Publication Date
GB201107176D0 true GB201107176D0 (en) 2011-06-15

Family

ID=44202940

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1107176.8A Ceased GB201107176D0 (en) 2011-04-28 2011-04-28 Pyrrolnitrin derivatives

Country Status (2)

Country Link
GB (1) GB201107176D0 (en)
WO (1) WO2012146936A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
TWI638802B (en) 2012-05-24 2018-10-21 芬蘭商奧利安公司 Catechol o-methyltransferase activity inhibiting compounds
WO2014110574A1 (en) 2013-01-14 2014-07-17 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
ES2790419T3 (en) 2013-01-15 2020-10-27 Incyte Holdings Corp Thiazolecarboxamide and pyridinecarboxamide compounds useful as PIM kinase inhibitors
US9556197B2 (en) 2013-08-23 2017-01-31 Incyte Corporation Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
WO2016010897A1 (en) 2014-07-14 2016-01-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
CN104803914B (en) * 2015-03-05 2017-11-14 成都理工大学 Hexahydro azatropylidene oxybenzamide class compound as Rho kinase inhibitors
US9540347B2 (en) 2015-05-29 2017-01-10 Incyte Corporation Pyridineamine compounds useful as Pim kinase inhibitors
JP6902025B2 (en) * 2015-06-18 2021-07-14 ティン セラピューティックス エルエルシー Methods and compositions for the prevention and treatment of hearing loss
AR105967A1 (en) 2015-09-09 2017-11-29 Incyte Corp SALTS OF A PIM QUINASA INHIBITOR
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
MX393780B (en) 2017-01-17 2025-03-24 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
TW201924683A (en) 2017-12-08 2019-07-01 美商英塞特公司 Low dose combination therapy for treatment of myeloproliferative neoplasms
WO2020049208A1 (en) * 2018-09-09 2020-03-12 Fundacio Privada Institut De Recerca De La Sida - Caixa Aurora kinase as target for treating, preventing or curing hiv infection or aids
CN110327465B (en) * 2019-07-06 2021-12-14 五邑大学 A compound anti-prostate cancer drug
CN110974828B (en) * 2019-12-24 2023-03-31 苏州大学 Application of compound Axitinib in preparation of medicine for treating cerebrovascular diseases and pharmaceutical composition of compound Axitinib
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
CN115611927A (en) * 2020-01-06 2023-01-17 刘力 New Compounds of Changchun Antineoplastic Drugs
EP4126014A4 (en) * 2020-03-23 2024-04-17 The Board Of Regents Of The University Of Texas System Combination therapeutics using tumor treating fields (ttfields)
US11857551B1 (en) 2020-07-10 2024-01-02 Ting Therapeutics Llc Methods for the prevention and treatment of hearing loss
US12070465B2 (en) * 2020-09-15 2024-08-27 Ting Therapeutics Llc Compositions and methods for the prevention and treatment of hearing loss
IL305165A (en) 2021-02-19 2023-10-01 Sudo Biosciences Ltd TYK2 inhibitors and their uses
MX2023009682A (en) 2021-02-19 2023-10-30 Sudo Biosciences Ltd Tyk2 inhibitors and uses thereof.
US20230099109A1 (en) * 2021-09-30 2023-03-30 Regeneron Pharmaceuticals, Inc. Treatment Of Glaucoma With Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors
EP4504335A2 (en) 2022-04-01 2025-02-12 The Board Of Regents Of The University Of Texas System Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018737B1 (en) 1979-04-11 1983-11-09 Mitsui Petrochemical Industries, Ltd. Process for producing spherical carrier particles for olefin polymerisation catalyst, catalyst comprising such carrier particles, and use of such catalyst in olefin polymerisation
JPH07147016A (en) 1993-11-24 1995-06-06 Matsushita Electric Ind Co Ltd In-line type sputtering system
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
US6353016B1 (en) * 1998-01-14 2002-03-05 Nippon Shinyaku Co., Ltd. Potassium channel activators
HK1042656A1 (en) 1999-03-25 2002-08-23 三菱制药株式会社 Preventives/remedies for interstitial pneumonia and pulmonary fibrosis
WO2000078351A1 (en) 1999-06-18 2000-12-28 Mitsubishi Pharma Corporation Osteogenesis promoters
US6623513B2 (en) * 2001-01-19 2003-09-23 Advanced Photodynamic Technologies, Inc. Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
CA2705815A1 (en) * 2007-11-17 2009-05-22 Bayer Consumer Care Ag Topical drugs for use in antifungal therapy
WO2011146031A1 (en) * 2010-05-18 2011-11-24 Bilgic Mahmut Pharmaceutical composition comprising n- acetylcysteine and a xanthine

Also Published As

Publication number Publication date
WO2012146936A1 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
GB201107176D0 (en) Pyrrolnitrin derivatives
SG10201601802YA (en) Dispiropyrrolidine derivatives
ZA201401884B (en) New dihydroquinoline-2-one derivatives
IL222646A0 (en) N3-substituted -n1-sulfonyl-5-fluoropyrimidinone derivatives
PL2590974T3 (en) Tetrahydro-pyrido-pyrimidine derivatives
SG11201401937YA (en) New aryl-quinoline derivatives
IL247640A0 (en) Heteroarylpiperidine derivatives
EP2687531A4 (en) Tetrahydrocarboline derivative
ZA201402453B (en) Insecticidal 2-methoxybenzamide derivatives
EP2740730A4 (en) Dibenzooxepin derivative
EP2688580A4 (en) Vancomycin derivatives
GB2490849B (en) Di-aspirin derivatives
IL233001A0 (en) Novel iso-ergoline derivatives
HU1000243D0 (en) 8-hidroxy-quinoline derivatives
SI2766342T1 (en) Phenyl-guanidine derivatives
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives
AU4553P (en) WES04 Westringia fruticosa
GB201115238D0 (en) Pit-stop easy
ZA201209248B (en) Amido-tropane derivatives
IL220983A0 (en) 2-aldoximino-5-fluoropyrimidine derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)